| Title | Mechanism of SEMA3G knockdown-mediated attenuation of high-fat diet-induced obesity |
| Authors | Liu, Min Xie, Shuo Liu, Weiwei Li, Jingjin Li, Chao Huang, Wei Li, Hexin Song, Jinghai Zhang, Hong |
| Affiliation | Peking Univ, Hlth Sci Ctr, Inst Cardiovasc Sci, Beijing, Peoples R China Peking Univ, Hlth Sci Ctr, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China Peking Univ, Hosp 1, Dept Geriatr Med, Beijing, Peoples R China Beijing Hosp, Biol Sample Management Ctr, Beijing, Peoples R China Beijing Hosp, Dept Surg, Beijing, Peoples R China |
| Keywords | ENDOTHELIAL-CELL MIGRATION CLASS 3 SEMAPHORINS PPAR-GAMMA INSULIN-RESISTANCE ADIPOSE EXPRESSION DIFFERENTIATION RECEPTORS HEALTH INJURY |
| Issue Date | Jan-2020 |
| Publisher | JOURNAL OF ENDOCRINOLOGY |
| Abstract | Obesity is a worldwide health problem. Semaphorins are involved in axonal guidance; however, the role of secretory semaphorin 3G (SEMA3G) in regulating adipocyte differentiation remains unclear. Microarray analysis showed that the SEMA3G gene was upregulated in an in vitro model of adipogenesis. In this study, SEMA3G was highly expressed in the white adipose tissue and liver. Analysis of 3T3-L1 cell and primary mouse preadipocyte differentiation showed that SEMA3G mRNA and protein levels were increased during the middle stage of cell development. In vitro experiments also showed that adipocyte differentiation was promoted by SEMA3G; however, SEMA3G inhibition using a recombinant lentiviral vector expressing a specific shRNA showed the opposite results. Mice were fed a chow or high-fat diet (HFD); knockdown of SEMA3G was found to inhibit weight gain, reduce fat mass in the tissues, prevent lipogenesis in the liver tissue, reduce insulin resistance and ameliorate glucose tolerance in HFD mice. Additionally, the effect of SEMA3G on HFD-induced obesity was activated through PI3K/Akt/GSK3 beta signaling in the adipose tissue and the AMPK/SREBP-1c pathway in the liver. Moreover, the plasma concentrations of SEMA3G and leptin were measured in 20 obese and 20 non-obese human subjects. Both proteins were increased in obese subjects, who also exhibited a lower level of adiponectin and presented with insulin resistance. In summary, we demonstrated that SEMA3G is an adipokine essential for adipogenesis, lipogenesis, and insulin resistance and is associated with obesity. SEMA3G inhibition may, therefore, be useful for treating diet-induced obesity and its complications. |
| URI | http://hdl.handle.net/20.500.11897/584850 |
| ISSN | 0022-0795 |
| DOI | 10.1530/JOE-19-0029 |
| Indexed | SCI(E) |
| Appears in Collections: | 第一医院 |
